| Assay ID | Title | Year | Journal | Article |
|---|
| AID259070 | Displacement of [3H]SR141716A from human CB1 expressed in CHO cells at 10 uM | 2006 | Journal of medicinal chemistry, Jan-12, Volume: 49, Issue:1
| Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates. |
| AID259069 | Inhibitory activity against FAAH in Wistar rat brain homogenate | 2006 | Journal of medicinal chemistry, Jan-12, Volume: 49, Issue:1
| Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates. |
| AID185866 | Compound was tested for hypolipidemic activity in male Sprague-Dawley rats by measuring amount of liver cholesterol after administration of 600 mg dose per kg of diet | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5
| 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents. |
| AID187081 | The concentration required to reduce liver cholesterol half-way from the average orotic acid level to the basal level | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5
| 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents. |
| AID187082 | The concentration required to reduce liver triglyceride half-way from the average orotic acid level to the basal level | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5
| 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents. |
| AID189703 | The activity relative to DPTH in liver triglyceride | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5
| 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents. |
| AID259072 | Displacement of [3H]CP-55940 from human CB2 expressed in CHO cells at 10 uM | 2006 | Journal of medicinal chemistry, Jan-12, Volume: 49, Issue:1
| Substituted 2-thioxoimidazolidin-4-ones and imidazolidine-2,4-diones as fatty acid amide hydrolase inhibitors templates. |
| AID189702 | The activity relative to DPTH in liver cholesterol | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5
| 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents. |
| AID185855 | Compound was tested for hypolipidemic activity in male Sprague-Dawley rats by measuring amount of liver triglyceride after administration of 600 mg dose per kg of diet | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5
| 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents. |
| AID114124 | Anticonvulsant activity was measured from scMET test by delivering the drug intraperitoneally after 0.5 hr | 1991 | Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
| Synthesis and anticonvulsant activity of 2-iminohydantoins. |
| AID114123 | Anticonvulsant activity was measured from mES test by delivering the drug intraperitoneally after 0.5 hr; NA-Not active | 1991 | Journal of medicinal chemistry, Jun, Volume: 34, Issue:6
| Synthesis and anticonvulsant activity of 2-iminohydantoins. |
| AID171184 | Compound was tested for hypolipidemic activity in male Sprague-Dawley rats by measuring change in body weight after administration of 600 mg dose per kg of diet | 1986 | Journal of medicinal chemistry, May, Volume: 29, Issue:5
| 5,5-Diaryl-2-thiohydantoins and 5,5-diaryl-N3-substituted-2-thiohydantoins as potential hypolipidemic agents. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | | | |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588499 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588501 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Current protocols in cytometry, Oct, Volume: Chapter 13 | Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2006 | Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. |
| AID588497 | High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set | 2010 | Assay and drug development technologies, Feb, Volume: 8, Issue:1
| High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | | | |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |